| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Pharmacology (T.A., T.B., M.B.H.Y., Z.H.), Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel; INSERM U468 (F.D., S.A.), Hopital Henri Mondor, 94010 Creteil, France; and Department of Pediatrics (Z.H.), Rambam Medical Center, Haifa, 31096 Israel
Address all correspondence and requests for reprints to: Dr. Zeev Hochberg, Faculty of Medicine, Technion, P.O. Box 9649, Haifa 31096, Israel. E-mail: rprzeev{at}tx.technion.ac.il
Previously, we reported the identification of a new human GH receptor
(hGHR) messenger RNA species that encodes a smaller hGHR isoform,
termed hGHRtr. Its messenger RNA is expressed in several human tissues
and predicts a severely truncated GHR protein that lacks 97.5% of the
intracellular domain. Because these two hGHR isoforms, which display
similar binding affinity, are coexpressed in several tissues, they may
reside side by side and, therefore, interrelate. To further
characterize the biological properties of hGHRtr in comparison with
hGHR, we generated Chinese hamster ovary (CHO) cell lines stably
expressing each of these hGHR isoforms. Cross-linking of
[125I]hGH to CHO/hGHRtr cells revealed a majored specific
complex with apparent Mr of
100 kDa, which would indicate the hGHRtr
to be in molecular mass form of about 80 kDa. When compared with
CHO/hGHR, CHO/hGHRtr cells secreted higher amounts of soluble
GH-binding protein (GHBP). In contrast to CHO/hGHR cells, CHO/hGHRtr
cells did not exhibit any GH-induced receptor down-regulation, and
internalization was markedly reduced. Analysis of the constitutive
turnover of cellular hGHR and soluble GHBP showed that incubation of
CHO/hGHR cells with cycloheximide caused parallel disappearance of hGHR
and GHBP. This contrasted with the stability of GHRtr, which showed no
decline after cycloheximide treatment for up to 4 h, suggesting
that the bulk GHRtr and GHBP may be derived from preformed proteins.
Thus, in contrast to hGHR, hGHRtr is fixed at the cell membrane; it
undergoes minimal internalization, no down-regulation by hGH, no
constitutive turnover for as long as 4 h, but increased capacity
to generate a soluble GHBP. Because hGHRtr failed to undergo
ligand-induced internalization, the source of the continuous,
undisturbed GHBP released into the medium may be from an intracellular
storage pool. The relative abundance of these two hGHR isoforms,
through regulation of splicing, could be of critical importance in
modulating the biological effects of GH.
This article has been cited by other articles:
![]() |
P. E Mullis Genetic control of growth Eur. J. Endocrinol., January 1, 2005; 152(1): 11 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tiulpakov, P. Rubtsov, I. Dedov, V. Peterkova, O. Bezlepkina, G. P. Chrousos, and Z. Hochberg A Novel C-Terminal Growth Hormone Receptor (GHR) Mutation Results in Impaired GHR-STAT5 But Normal STAT-3 Signaling J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 542 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ji, S. J. Frank, and J. L. Messina Growth Hormone-induced Differential Desensitization of STAT5, ERK, and Akt Phosphorylation J. Biol. Chem., August 9, 2002; 277(32): 28384 - 28393. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Goodyer, R. M. O. Figueiredo, S. Krackovitch, L. De Souza Li, J. A. Manalo, and G. Zogopoulos Characterization of the growth hormone receptor in human dermal fibroblasts and liver during development Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1213 - E1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ballesteros, K.-C. Leung, R. J. M. Ross, T. P. Iismaa, and K. K. Y. Ho Distribution and Abundance of Messenger Ribonucleic Acid for Growth Hormone Receptor Isoforms in Human Tissues J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2865 - 2871. [Abstract] [Full Text] |
||||
![]() |
T. Amit, M. B. H. Youdim, and Z.'e. Hochberg Does Serum Growth Hormone (GH) Binding Protein Reflect Human GH Receptor Function? J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 927 - 932. [Abstract] [Full Text] |
||||
![]() |
M. Maamra, J. Finidori, S. Von Laue, S. Simon, S. Justice, J. Webster, S. Dower, and R. Ross Studies with a Growth Hormone Antagonist and Dual-fluorescent Confocal Microscopy Demonstrate that the Full-length Human Growth Hormone Receptor, but Not the Truncated Isoform, Is Very Rapidly Internalized Independent of Jak2-Stat5 Signaling J. Biol. Chem., May 21, 1999; 274(21): 14791 - 14798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iida, Y. Takahashi, H. Kaji, M. O. Takahashi, Y. Okimura, O. Nose, H. Abe, and K. Chihara Functional Characterization of Truncated Growth Hormone (GH) Receptor-(1-277) Causing Partial GH Insensitivity Syndrome with High GH-Binding Protein J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1011 - 1016. [Abstract] [Full Text] |
||||
![]() |
T. Amit, O. Bar-Am, F. Dastot, M. B. H. Youdim, S. Amselem, and Z.'e. Hochberg The Human Growth Hormone (GH) Receptor and Its Truncated Isoform: Sulfhydryl Group Inactivation in the Study of Receptor Internalization and GH-Binding Protein Generation Endocrinology, January 1, 1999; 140(1): 266 - 272. [Abstract] [Full Text] |
||||
![]() |
A. Edens and F. Talamantes Alternative Processing of Growth Hormone Receptor Transcripts Endocr. Rev., October 1, 1998; 19(5): 559 - 582. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |